Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-κB

Molecular and Cellular Biology

Volumn 18, Issue 6, 1998, Pages 3140-3148

  Kalli, Kimberly ^a   Huntoon, Catherine ^a   Bell, Michael ^a   McKean, David J ^a  

^a MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CYCLOSPORIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL NUCLEUS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

EID: 0031842613     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/mcb.18.6.3140     Document Type: Article

References (37)

1. Abraham, R. T., S. Ho, T. Barna, and D. J. McKean. 1987. Transmembrane signalling during IL-1-dependent T cell activation: interaction of signal 1-and signal 2-type mediators with the phosphoinositide-dependent signal transduction mechanism. J. Biol. Chem. 262:2719-2729.
2. Baldwin, A. S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
3. Bankers-Fulbright, J. L., K. J. Kalli, and D. J. McKean. 1996. IL-1 signal transduction. Life Sci. 59:61-83.
4. Brini, A. T., A. Harel-Bellan, and W. L. Farrar. 1990. Cyclosporin A inhibits induction of IL-2 receptor alpha chain expression by affecting activation of NF-κB-like factor(s) in cultured human T lymphocytes. Eur. Cytokine Netw. 1:131-139.
5. Chen, A., J. Hagler, V. J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets IκB-α to the ubiquitin-A proteasome pathway. Genes Dev. 9:1586-1597.
6. Chu, Z.-L., T. A. McKinsey, L. Liu, X. Qi, and D. W. Ballard. 1996. Basal phosphorylation of the PEST domain in IκBβ regulates its functional interaction with the c-rel proto-oncogene product. Mol. Cell. Biol. 16:5974-5984.
7. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1295-1304.
8. Dignam, J. D., R. M. Liebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475-1489.
9. Dobrzanski, P., R. P. Ryseck, and R. Bravo. 1994. Differential interactions of Rel-NF-kappa B complexes with I kappa B alpha determine pools of constitutive and inducible NF-kappa B activity. EMBO J. 13:4608-4609.
10. Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of the interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251:313-316.
11. Ghosh, P., T.-H. Tan, N. R. Rice, A. Sica, and H. A. Young. 1993. The interleukin 2 CD29-responsive complex contains at least three members of the NF-κB family: c-Rel, p50, and p65. Proc. Natl. Acad. Sci. USA 90:1696-1700.
12. Han, Y., and A. R. Brasier. 1997. Mechanism for biphasic RelA-NF-κB1 nuclear translocation in tumor necrosis factor α-stimulated hepatocytes. J. Biol. Chem. 272:9825-9832.
13. Harhaj, E. W., S. B. Maggirwar, L. Good, and S.-C. Sun. 1996. CD28 mediates a potent costimulatory signal for rapid degradation of IκBβ which is associated with accelerated activation of various NF-κB/Rel heterodimers. Mol. Cell. Biol. 16:6736-6743.
14. Hoyos, B., D. W. Ballard, E. Bohnlein, M. Siekevitz, and W. C. Greene. 1989. Kappa B-spccitic DNA binding proteins: role in the regulation of human interleukin-2 gene expression. Science 244:457-460.
15. Johnson, D. R., I. Douglas, A. Jahnke, S. Ghosh, and J. S. Pober. 1996. A sustained reduction in IκB-α may contribute to persistent NF-κB activation in human endothelial cells. J. Biol. Chem. 271:16317-16322.
16. June, C. H., J. A. Ledbetter, M. M. Gillespie, T. Lindsten, and C. B. Thompson. 1987. T-cell proliferation involving the CD28 pathway is associated with cyclosporin-resistant interleukin 2 gene expression. Mol. Cell. Biol. 7:4472-4481.
17. Kay, J. E., and C. R. Benzie. 1989/1990. T lymphocyte activation through the C28 (sic) pathway is insensitive to inhibition by the immunosuppressive drug FK-506. Immunol. Lett. 23:155-160.
18. Köntgen, F., R. J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlington, and S. Gerondakis. 1995. Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression. Genes Dev. 9:1965-1977.
19. Lai, J. H., and T. H. Tan. 1994. CD28 signaling causes a sustained down-regulation of IκBα which can be prevented by the immunosuppressant rapamycin. J. Biol. Chem. 269:30077-30080.
20. Le Bail, O., R. Schmidt-Ullrich, and A. Israel. 1993. Promoter analysis of the gene encoding the IκB-α/MAD3 inhibitor of NF-κB: positive regulation by members of the rel/NFκB family. EMBO J. 12:5043-5049.
21. McCaffrey, P. G., P. K. Kim, V. E. Valge-Archer, R. Sen, and A. Rao. 1994. Cyclosporin A sensitivity of the NF-kappa B site of the IL2R alpha promoter in untransformed murine T cells. Nucleic Acids Res. 22:2134-2142.
22. McKean, D. J., M. Bell, C. Huntoon, S. Rastogi, M. Van Norstrand, R. Podzorski, A. Nilson, and C. Paya. 1995. IL-1 receptor and TCR signals synergize to activate NF-κB-mediated gene transcription. Int. Immunol. 7:9-20.
23. McKean, D. J., C. Huntoon, and M. Bell. 1994. Ligand-induced desensitizalion of inlerlcukin 1 receptor-initiated intracellular signaling events in T helper lymphocytes. J. Exp. Med. 180:1321-1328.
24. Mercurio, F., J. A. DiDonato, C. Rosette, and M. Karin. 1993. p105 and p98 precursor proteins play an active role in NF-κB-mediated signal transduction. Genes Dev. 7:705-718.
25. Molitor, J. A., W. H. Walker, S. Doerre, D. W. Ballard, and W. C. Greene. 1990. NF-kappa B: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc. Natl. Acad. Sci. USA 87: 10028-10032.
26. Pimentel-Muinos, F. X., J. Mazana, and M. Fresno. 1995. Biphasic control of nuclear factor-kappa B activation by the T cell receptor complex: role of tumor necrosis factor alpha. Eur. J. Immunol. 25:179-186.
27. Rudd, C. E. 1996. Upstream-downstream: CD28 cosignaling pathways and T cell function. Immunity 4:527-534.
28. Su, M. S., and A. Semerjian. 1991. Activation of transcription factor NF kappa B in Jurkat cells is inhibited selectively by FK 506 in a signal-dependent manner. Transplant. Proc. 23:2912-2915.
29. Suyang, H., R. Phillips, I. Douglas, and S. Ghosh. 1996. Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB. Mol. Cell. Biol. 16:5444-5449.
30. Thompson, J. E., R. J. Phillips, H. Erdjument-Bromage, P. Tempst, and S. Ghosh. 1995. IκB-β regulates the persistent response in a biphasic activation of NF-κB. Cell 80:573-582.
31. Traenckner, E. B., H. L. Pahl, T. Henkel, K. N. Schmidt, S. Wilk, and P. A. Baeuerle. 1995. Phosphorylation of human IκB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J. 14:2876-2883.
32. Van Wauwe, J., and J. G. Goossens. 1981. Monoclonal anti-human T lymphocyte antibodies: enumeration and characterization of T cell subsets. Immunology 42:157-164.
33. Venkataraman, L., S. J. Burakoff, and R. Sen. 1995. FK506 inhibits antigen receptor-mediated induction of c-Rel in B and T lymphoid cells. J. Exp. Med. 181:1091-1099.
34. Verweij, C. L., M. Geerts, and L. A. Aarden. 1991. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element. J. Biol. Chem. 266:14179-14182.
35. Wang, W., W. F. Tam, C. C. W. Hughes, S. Rath, and R. Sen. 1997. c-Rel is a target of pentoxifylline-mediated inhibition of T-lymphocyte activation. Immunity 6:165-174.
36. Weil, R., C. Laurent-Winter, and A. Israel. 1997. Regulation of IκBβ degradation. J. Biol. Chem. 272:9942-9949.
37. Zhang, L., and G. J. Nabel. 1994. Positive and negative regulation of IL-2 gene expression: role of multiple regulatory sites. Cytokine 6:221-228.